LURAP1L-AS1

Across TCGA pan-cancer cohorts, LURAP1L-AS1 RNA differs between tumor and matched normal tissue in 11 of 18 cancer types tested, making tumor–normal expression one of LURAP1L-AS1’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where LURAP1L-AS1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LURAP1L-AS1 is over-expressed in tumor.

STAD, KICH, and KIRP are the cancer types where LURAP1L-AS1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LURAP1L-AS1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	Male	All	+0.295	.009	6	view →
KICH	All	All	+0.475	.004	5	view →
KIRP	Male	All	+0.140	.003	5	view →
PAAD	All	All	+0.332	.003	4	view →
BRCA	Female	All	+0.250	<.001	4	view →
COAD	Female	II,III,IV	+0.154	.004	4	view →
HNSC	All	All	+0.128	.016	4	view →
KIRC	Male	All	+0.114	<.001	3	view →
ESCA	Female	All	+0.940	.001	2	view →
CHOL	Female	All	+0.460	.031	1	view →
LUAD	Female	II,III,IV	+0.132	.048	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 11 strongest of 11 lineages.

LURAP1L-AS1–STAD

Open the STAD breakdown →